中文｜English
ISSN 1001-5256 (Print)
ISSN 2097-3497 (Online)
CN 22-1108/R
Volume 38 Issue 11
Nov.  2022
Turn off MathJax
Article Contents
Article Navigation >  Journal of Clinical Hepatology  > 2022  >  38(11): 2568-2570

A case of type 3 progressive familial intrahepatic cholestasis

DOI: 10.3969/j.issn.1001-5256.2022.11.025
  • 1.

    Department of Digestive Endocrinology, Chengdu District People's Jinniu Hospital, Sichuan Provincial People's Hospital, Chengdu 610036, China

  • 2.

    Department of Gastroenterology and Hepatology, Sichuan Academy of Medical Sciences & Sichuan Provincial People's Hospital, Chengdu 610072, China

Research funding:

Chengdu Science and Technology Bureau Technology Innovation R & D Project (2021-YF05-01040-SN)

More Information
  • Corresponding author: LEI Lei, leileixhnk@qq.com(ORCID: 0000-0002-3725-1968)
  • Received Date: 2022-03-13
  • Accepted Date: 2022-05-11
  • Published Date: 2022-11-20
    Abstract
    • FullText(HTML)
  • loading
    • References(8)
  • [1]
    LIPIŃSKI P, JANKOWSKA I. Progressive familial intrahepatic cholestasis type 3[J]. Dev Period Med, 2018, 22(4): 385-389. DOI: 10.34763/devperiodmed.20182204.385389.
    [2]
    AMIRNENI S, HAEP N, GAD MA, et al. Molecular overview of progressive familial intrahepatic cholestasis[J]. World J Gastroenterol, 2020, 26(47): 7470-7484. DOI: 10.3748/wjg.v26.i47.7470.
    [3]
    LI AQ, DONG Y, XU ZQ, et al. Progressive familial intrahepatic cholestasis type 3: A report of two cases in one pedigree[J]. J Clin Hepatol, 2020, 36(7): 1601-1604. DOI: 10.3969/j.issn.1001-5256.2020.07.032.

    李爱芹, 董漪, 徐志强, 等. 进行性家族性肝内胆汁淤积症3型一家系2例报告[J]. 临床肝胆病杂志, 2020, 36(7): 1601-1604. DOI: 10.3969/j.issn.1001-5256.2020.07.032.
    [4]
    STÄTTERMAYER AF, HALILBASIC E, WRBA F, et al. Variants in ABCB4 (MDR3) across the spectrum of cholestatic liver diseases in adults[J]. J Hepatol, 2020, 73(3): 651-663. DOI: 10.1016/j.jhep.2020.04.036.
    [5]
    GUNAYDIN M, BOZKURTER CIL AT. Progressive familial intrahepatic cholestasis: diagnosis, management, and treatment[J]. Hepat Med, 2018, 10: 95-104. DOI: 10.2147/HMER.S137209.
    [6]
    DEGIORGIO D, COLOMBO C, SEIA M, et al. Molecular characterization and structural implications of 25 new ABCB4 mutations in progressive familial intrahepatic cholestasis type 3 (PFIC3)[J]. Eur J Hum Genet, 2007, 15(12): 1230-1238. DOI: 10.1038/sj.ejhg.5201908.
    [7]
    REICHERT MC, LAMMERT F. ABCB4 gene aberrations in human liver disease: An evolving spectrum[J]. Semin Liver Dis, 2018, 38(4): 299-307. DOI: 10.1055/s-0038-1667299.
    [8]
    LAZARIDIS KN, GORES GJ, LINDOR KD. Ursodeoxycholic acid 'mechanisms of action and clinical use in hepatobiliary disorders'[J]. J Hepatol, 2001, 35(1): 134-146. DOI: 10.1016/s0168-8278(01)00092-7.
    • Relative Articles
    • Supplements(0)
    • Cited By
  • 加载中

Catalog

    通讯作者: 陈斌, bchen63@163.com
    • 1. 

      沈阳化工大学材料科学与工程学院 沈阳 110142

    1. 本站搜索
    2. 百度学术搜索
    3. 万方数据库搜索
    4. CNKI搜索

    Figures(4)

    Get Citation
    PDF
    XML

    Article Metrics

    Article views (672) PDF downloads(44) Cited by()
    Proportional views
    Related
        

    The first journal specializing in hepatobiliary and pancreatic diseases in China

    Supervisor：Ministry of Education of the People's Republic of China

    Sponsor：Jilin University

    Academic Support: Chinese Society of Hepatology，Chinese Medical Association

    Address: 461 Xinjiang Road, Changchun

    Submit：0431-88782044

    Peer review：0431-88783542

    Email：lcgdb@vip.163.com

    About Journal

    Submission Guideline

    Journal Online

    Hepatobiliary College

    Guidelines

    YesterdayIP[]YesterdayPV[]TodayIP[]TodayPV[]Online[]

    Website Design © 2020 Editorial Board of Journal of Clinical Hepatology 吉ICP备10000617号-1 Supported by: Beijing Renhe Information Technology Co. Ltd  

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return